Name: Hormone Replacement Therapy and Risk of Venous Thromboembolism: Systematic Evidence Review Number 11 (en Inglés)
Price: 24520.00 CLP
Availability: InStock
Author: And Quality, Agency for Healthcare Resea ; Human Services, U. S. Department of Heal
ISBN: 9781490565750

portada Hormone Replacement Therapy and Risk of Venous Thromboembolism: Systematic Evidence Review Number 11 (en Inglés)

Formato

Libro Físico

Autor

U. S. Department of Heal Human Services

Agency for Healthcare Resea And Quality

Editorial

Createspace Independent Publishing Platform

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

28.0 x 21.6 x 0.3 cm

Peso

0.17 kg.

ISBN13

9781490565750

Categorías

Investigación médica

Hormone Replacement Therapy and Risk of Venous Thromboembolism: Systematic Evidence Review Number 11 (en Inglés)

U. S. Department of Heal Human Services (Autor) · Agency for Healthcare Resea And Quality (Autor) · Createspace Independent Publishing Platform · Tapa Blanda

Libro Nuevo

$ 24.520

$ 40.870

Ahorras: $ 16.350

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Lunes 12 de Agosto y el Lunes 19 de Agosto.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Hormone Replacement Therapy and Risk of Venous Thromboembolism: Systematic Evidence Review Number 11 (en Inglés)"

In this systematic evidence review (SER), we evaluate data on the relationship between the use of postmenopausal hormone replacement therapy (HRT) and selective estrogen receptor modulators (SERMs) and the risk for venous thromboembolism. We present results of a review of the literature and a meta-analysis of studies reporting data on postmenopausal HRT and venous thromboembolism. This report is part of a larger project on the risks and benefits of HRT prepared for the U.S. Preventive Services Task Force (USPSTF) to assist them in making recommendations. The emerging emphasis on women's health, coupled with an aging population, makes it increasingly important for primary care physicians to be familiar with the risks and benefits of postmenopausal HRT. Although postmenopausal HRT is widely used, it poses important health risks. One suspected risk is an increase in venous thromboembolic events. Initially, this relationship was based on studies of oral contraceptives and was not supported by studies of HRT. Findings from more recent studies, however, indicate an increase in risk.